Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650.

Ladel S, Schlossbauer P, Flamm J, Luksch H, Mizaikoff B, Schindowski K

Open source

DOI
10.3390/pharmaceutics11080367
Published
2019 Aug 1
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics11080367,
  title = {Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650.},
  author = {Ladel S and Schlossbauer P and Flamm J and Luksch H and Mizaikoff B and Schindowski K},
  year = {2019},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics11080367},
  url = {https://doi.org/10.3390/pharmaceutics11080367}
}

RIS

TY  - JOUR
TI  - Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650.
AU  - Ladel S
AU  - Schlossbauer P
AU  - Flamm J
AU  - Luksch H
AU  - Mizaikoff B
AU  - Schindowski K
PY  - 2019
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics11080367
UR  - https://doi.org/10.3390/pharmaceutics11080367
ER  - 

APA

S, L., P, S., J, F., H, L., B, M., & K, S. (2019). Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics11080367

Source records